MHC allele-specific binding of a malaria peptide makes it become promiscuous on fitting a glycine residue into pocket 6

被引:29
作者
Vargas, LE
Parra, CA
Salazar, LM
Guzmán, F
Pinto, M
Patarroyo, ME
机构
[1] Fdn Inst Inmunol Colombia, FIDIC, Bogota, Colombia
[2] Univ Nacl Colombia, Bogota, Colombia
关键词
Plasmodium falciparum; MSP-1; peptide; pocket; 6; promiscuous peptide; peptide binding assays; binding motifs; synthetic vaccines; HLA-DR molecules; class II molecules; HLA-HLA DRB1*01 alleles;
D O I
10.1016/S0006-291X(03)01129-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Peptide 1585 (EVLYLKPLAGVYRSLKKQLE) has a highly conserved amino-acid sequence located in the Plasmodium falciparum main merozoite surface protein (MSP-1) C-terminal region, required for merozoite entry into human erythrocytes and therefore represents a vaccine candidate for P. falciparum malaria. Original sequence-specific binding to five HLA DRB1* alleles (0101, 0102, 0401, 0701, and 1101) revealed this peptide's specific HLA DRB1*0102 allele binding. This peptide's allele-specific binding to HLA DRB1*0102 took on broader specificity for the DRB1*0101, -0401, and -1101 alleles when lysine was replaced by glycine in position 17 (peptide 5198: EVLYLKPLAGVYRSLKG(17)QLE). Binding of the identified G(10)VYRSLKGQLE(20) C-terminal register to these alleles suggests that peptide promiscuous binding relied on fitting Y-12, L-15, and G(17) into P-1, P-4, and P-6, respectively. The implications of the findings and the future of this synthetic vaccine candidate are discussed. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:148 / 156
页数:9
相关论文
共 39 条
[1]   Rational antigen modification as a strategy to upregulate or downregulate antigen recognition [J].
Abrams, SI ;
Schlom, J .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (01) :85-91
[2]   The use of bioinformatics for identifying class II-restricted T-cell epitopes [J].
Bian, HJ ;
Reidhaar-Olson, JF ;
Hammer, J .
METHODS, 2003, 29 (03) :299-309
[3]   STRUCTURE OF THE HUMAN CLASS-I HISTOCOMPATIBILITY ANTIGEN, HLA-A2 [J].
BJORKMAN, PJ ;
SAPER, MA ;
SAMRAOUI, B ;
BENNETT, WS ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1987, 329 (6139) :506-512
[4]  
BOEHNCKE WH, 1993, J IMMUNOL, V150, P331
[5]  
Bristol JA, 1998, J IMMUNOL, V160, P2433
[6]  
CalvoCalle JM, 1997, J IMMUNOL, V159, P1362
[7]   Distorting malaria peptide backbone structure to enable fitting into MHC class II molecules renders modified peptides immunogenic and protective [J].
Cifuentes, G ;
Patarroyo, ME ;
Urquiza, M ;
Ramirez, LE ;
Reyes, C ;
Rodriguez, R .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (11) :2250-2253
[8]  
Clay TM, 1999, J IMMUNOL, V162, P1749
[9]   Alpha helix shortening in 1522 MSP-1 conserved peptide analogs is associated with immunogenicity and protection against P-falciparum malaria [J].
Cubillos, M ;
Espejo, F ;
Purmova, J ;
Martinez, JC ;
Patarroyo, ME .
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2003, 50 (03) :400-409
[10]  
Espejo F, 2001, ANGEW CHEM INT EDIT, V40, P4654, DOI 10.1002/1521-3773(20011217)40:24<4654::AID-ANIE4654>3.0.CO